Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Roy Mages

Adolescent Medicine Taylors, SC Medical Doctor

NPI 1730148289 CMS profile 351363

4501 Old Spartanburg Rd, Suite 9, Taylors, SC 29687

Open in the dashboard

General payments

$2,537

135 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Roy Mages of Taylors, SC is reported in the CMS Open Payments database as having received $2,537 across 135 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Adolescent Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $287 15
2024 General $601 18
2023 General $305 17
2022 General $418 27
2021 General $392 23
2020 General $304 20
2019 General $230 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Roy Mages
  • Adolescent Medicine median
  • Middle half of Adolescent Medicine
  • National median

In program year 2025, general payments to Roy Mages were reported at $287. Among 914 Adolescent Medicine profiles paid that year, the median was $100 and the middle half received between $40 and $207.

Show as a table
Year Roy Mages Adolescent Medicine median Middle half National median
2019 $230 $95 $36–$198 $163
2020 $304 $50 $23–$111 $114
2021 $392 $67 $27–$179 $132
2022 $418 $79 $29–$189 $149
2023 $305 $100 $39–$194 $160
2024 $601 $93 $38–$195 $164
2025 $287 $100 $40–$207 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ironshore Pharmaceuticals Inc. $605 39 payments
  2. Supernus Pharmaceuticals, Inc. $446 11 payments
  3. Tris Pharma Inc $442 25 payments
  4. Corium, Inc. $297 15 payments
  5. Cranial Technologies, Inc $115 6 payments
  6. Neos Therapeutics, LP $115 8 payments
  7. Pfizer Inc. $103 6 payments
  8. Sanofi-Aventis U.S. LLC $98 5 payments
  9. Sanofi Pasteur Inc. $83 5 payments
  10. Collegium Pharmaceutical, Inc. $73 4 payments
  11. Other $158 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,537 135 payments
Products named General payments · program years 2019–2025
  1. Qelbree $386 7 payments
  2. JORNAY PM Central Nervous Stimulant ADHD $381 26 payments
  3. Azstarys $297 15 payments
  4. JORNAY PM Central Nervous System Stimulant $166 9 payments
  5. Dyanavel XR Adhd $159 9 payments
  6. Quillivant XR $133 8 payments
  7. Doc Band $115 6 payments
  8. COTEMPLA XR-ODT $98 7 payments
  9. TZIELD $98 5 payments
  10. Dyanavel XR Adhd $97 5 payments
  11. Other $972 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

135 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adolescent Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record